Maravai LifeSciences Announces November 2021 Investor Conference Schedule
November 02 2021 - 8:30AM
Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of
life science reagents and services to researchers and biotech
innovators, is scheduled to participate in the following virtual
investor conferences during the month of November.
On November 17, 2021, Kevin Herde, Chief Financial Officer, will
participate in a fireside chat at the Stifel Healthcare Conference
at 10:20 a.m. PT.
On November 30, 2021, Kevin Herde, Chief Financial Officer,
will present at the Nasdaq Investor Conference at 7:00 a.m.
PT.
A live webcast of the presentations will be available to all
interested parties on the Maravai Lifesciences investor relations
website at http://investors.maravai.com. An archived version
of the webcast will be available shortly after the completion of
each event on the Maravai investor relations website.
About Maravai Maravai is a leading life
sciences company providing critical products to enable the
development of drug therapies, diagnostics, novel vaccines and to
support research on human diseases. Maravai’s companies are leaders
in providing products and services in the fields of nucleic acid
synthesis and biologic safety testing to many of the world's
leading biopharmaceutical, vaccine, diagnostics, and cell and gene
therapy companies. For more information about Maravai LifeSciences,
visit www.maravai.com.
Contact Information:
Media Contact: Sara Michelmore
MacDougall Advisors
+1 781-235-3060
maravai@macbiocom.com
Investor Contact: Deb Hart
Maravai LifeSciences
+ 1 858-988-5917
ir@maravai.com
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Maravai LifeSciences (NASDAQ:MRVI)
Historical Stock Chart
From Apr 2023 to Apr 2024